Medical News

RSS

Unrestricted availability of food can trigger overconsumption and obesity

Some of the same brain mechanisms that fuel drug addiction in humans accompany the emergence of compulsive eating behaviors and the development of obesity in animals, according to research funded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health.

29 Mar 2010

GHX to cut another $5 billion from healthcare costs

In the debate over healthcare reform, the healthcare supply chain has been largely overlooked as an effective way to reduce the cost of healthcare. Yet GHX and a collaborative community of healthcare providers, manufacturers, distributors and group purchasing organizations (GPOs) have already documented more than $1.3 billion in savings, and are on track to cut another $5 billion from the cost of healthcare over the next 5 years.

29 Mar 2010

$Vivakor, Eco Scientific Lab partner to commercialize VIVABlend and digital photo refractor screening device$

Vivakor, Eco Scientific Lab partner to commercialize VIVABlend and digital photo refractor screening device

Vivakor, Inc. announced today that it has partnered with Eco Scientific Lab, Inc. for commercialization of two Vivakor products. The first is the phytochemical rich nutraceutical beverage, VIVABlend™, developed exclusively by Vivakor and currently being sold in the direct to consumer market by Regeneca International, Inc.

29 Mar 2010

Prolucent Workforce Management acquires intellectual property assets from Symbio Solutions

Prolucent™ Workforce Management, the leading partner for healthcare providers seeking to optimize deployment of their workforce, today announced the acquisition of intellectual property assets from Symbio Solutions, Inc. The asset acquisition further strengthens Prolucent's best-of-breed workforce management software platform and will help Prolucent deliver even greater value to the more than 1,000 acute-care hospitals and staffing agencies it currently serves.

29 Mar 2010

FDA grants SynCardia Systems conditional approval to conduct IDE study of Freedom driver system

SynCardia Systems, Inc., manufacturer of the SynCardia temporary CardioWest™ Total Artificial Heart, today announced it has received conditional approval from the U.S. Food and Drug Administration (FDA) to conduct an Investigational Device Exemption (IDE) clinical study of the Freedom™ driver system, the first-ever U.S. portable driver designed to power SynCardia's Total Artificial Heart.

29 Mar 2010

Health Robotics launches global Beta installation of 3 i.v.SOFT Workflow Engine automation modules

Health Robotics today announced the successful global launch of the Beta Installation kick-off for its 3 latest i.v.SOFT Workflow Engine software automation modules [Assist, Label+ and Profile] in Nice [France], the 2010 venue for the European Association of Hospital Pharmacists. i.v.SOFT helps Pharmacy Technicians, I.V. Room Supervisors, and Pharmacy Directors to compound and manage the safe and efficient manual production of IV Admixtures according to hospital-defined sterile compounding guidelines, and to help bring the pharmacies into compliance with USP 797 regulations in the United States and GMP guidelines elsewhere.

29 Mar 2010

Today's OpEds: The states' lawsuits, the need to trim health costs and industry winners

No sooner had President Obama signed comprehensive health care reform than the attorneys general of 14 states scurried to the federal courts to challenge the law. ... [they] are doing a disservice to their constituents by opposing Medicaid expansion and a mandate that everyone buy insurance, with subsidies for low- and middle-income people (3/28).

29 Mar 2010

Generex Biotechnology announces FDA Expanded Access Treatment IND Program for Generex Oral-lyn

Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it has expanded its plans for its United States Food and Drug Administration (FDA) Expanded Access Treatment IND Program for its flagship product, Generex Oral-lyn™, to include licensed and qualified Nurse Practitioners in the United States.

29 Mar 2010

Neogen's third-quarter fiscal 2010 revenues up 21%

Neogen Corporation announced today that its net income for the third quarter of FY 2010, which ended Feb. 28, increased 38% from the previous year to $3,881,000. Adjusted for a 3-for-2 stock split effective Dec. 15, net income in the quarter rose to $0.17 per share, compared to the prior year's $0.12.

29 Mar 2010

Chakra Biotech completes MYR18.2m Series B investment round

Chakra Biotech Sdn Bhd, a Malaysian based Contract Research Organization, has completed a MYR18.2m Series B funding round. This brings total funding for the company to MYR20.0m. Malaysian Life Sciences Capital Fund Ltd. (MLSCF) and the Malaysian Technology Development Corporation Sdn Bhd (MTDC) participated in the round.

29 Mar 2010

As CMS nominee, Berwick would face changes and challenges

President Barack Obama will soon nominate Dr. Donald M. Berwick to "run Medicare and Medicaid, the programs that serve nearly one-third of all Americans, administration officials said Saturday," The New York Times reports.

29 Mar 2010

Alphatec Holdings closes acquisition of Scient'x Groupe

Alphatec Holdings, Inc., the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on treating conditions affecting the aging spine, announced today the closing of its previously announced acquisition of Scient'x Groupe SAS, a spinal implant company headquartered in France.

29 Mar 2010

FDA grants IDE approval for Urovalve's Surinate Bladder Management System

Urovalve, a medical device company focused on creating superior products for urinary flow and control, announced today that the U.S. Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval for the Company's Surinate® Bladder Management System, allowing Urovalve to conduct a clinical study for the Company's lead device in the United States.

29 Mar 2010

Closing Medicare drug gap helps Democrats sell reform

Kaiser Health News writer Christopher Weaver, in a story produced in collaboration with the Los Angeles Times, looks at the government's plan to close the Medicare prescription drug "doughnut hole."

29 Mar 2010

Interim data comparing Cervista HPV HR to Hybrid Capture 2 presented at 4th Biennial Meeting of AOGIN

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that interim data from the first large-scale independent evaluation of clinical performance of Cervista® HPV HR compared to Hybrid Capture 2 (hc2), were presented at the 4th Biennial Meeting of AOGIN (Asia-Oceanic Research Organization in Genital Infection and Neoplasia) in New Delhi, India on March 26-28, 2010.

29 Mar 2010

HealthCare.com launches new online resource for Medicare Supplemental information and quotes

HealthCare.com, Inc. the leader in online health insurance information and plan quotes, today announced the launch of MedicareSupplemental.com, a new website aimed to be the premier online resource for Medicare Supplemental information and quotes. The website provides extensive information to help consumers understand the complexities of Medicare Supplemental or "Medigap" coverage as well as a search tool to obtain quotes and connect with multiple brokers and agents.

29 Mar 2010

Final results from Novavax' Phase II clinical trial of trivalent seasonal influenza VLP vaccine announced

Novavax, Inc. a clinical-stage vaccine company, released the final results from a Phase II clinical trial evaluating Novavax's trivalent seasonal influenza Virus-like particle (VLP) vaccine candidate in healthy adults. The study enrolled healthy volunteers 18 to 49 years in age who were immunized with a single injection of Novavax's trivalent seasonal influenza VLP vaccine matched to the influenza strains recommended for the 2008-2009 influenza vaccine.

29 Mar 2010

Ligand Pharmaceuticals' LGD-4033 SARM Phase I study data featured at 14th endocrinology congress

Ligand Pharmaceuticals Incorporated today announced that data from a Phase I study with its selective androgen receptor modulator (SARM) LGD-4033 was featured today in a poster presentation at the 14th International Congress of Endocrinology in Kyoto, Japan. This Phase I clinical trial was the first study in humans of LGD-4033, and evaluated the safety, tolerability and pharmacokinetic profiles of the molecule in a single escalating dose, double blind, placebo-controlled study in 48 healthy volunteers.

29 Mar 2010

AlphaRx plans listing of subsidiary on Canadian exchange

AlphaRx, Inc. today announced that the Company plans to list its' Canadian subsidiary, which has been focused on China and emerging markets, on a Canadian exchange in a transaction that will result in two independent and highly focused public companies - one dedicated to the Far East and one to developed markets.

29 Mar 2010

Oxygen Biotherapeutics commences distributing newly formulated Dermacyte Oxygen Concentrate

Oxygen Biotherapeutics, Inc. today announced that the company has begun distribution for its newly formulated Dermacyte™ Oxygen Concentrate for the beauty and skin care market. The over-the-counter product is a scientifically designed perfluorocarbon concentrate to enhance oxygen delivery to skin.

29 Mar 2010

Medical News

Unrestricted availability of food can trigger overconsumption and obesity

GHX to cut another $5 billion from healthcare costs

Vivakor, Eco Scientific Lab partner to commercialize VIVABlend and digital photo refractor screening device

Prolucent Workforce Management acquires intellectual property assets from Symbio Solutions

FDA grants SynCardia Systems conditional approval to conduct IDE study of Freedom driver system

Health Robotics launches global Beta installation of 3 i.v.SOFT Workflow Engine automation modules

Today's OpEds: The states' lawsuits, the need to trim health costs and industry winners

Generex Biotechnology announces FDA Expanded Access Treatment IND Program for Generex Oral-lyn

Neogen's third-quarter fiscal 2010 revenues up 21%

Chakra Biotech completes MYR18.2m Series B investment round

As CMS nominee, Berwick would face changes and challenges

Alphatec Holdings closes acquisition of Scient'x Groupe

FDA grants IDE approval for Urovalve's Surinate Bladder Management System

Closing Medicare drug gap helps Democrats sell reform

Interim data comparing Cervista HPV HR to Hybrid Capture 2 presented at 4th Biennial Meeting of AOGIN

HealthCare.com launches new online resource for Medicare Supplemental information and quotes

Final results from Novavax' Phase II clinical trial of trivalent seasonal influenza VLP vaccine announced

Ligand Pharmaceuticals' LGD-4033 SARM Phase I study data featured at 14th endocrinology congress

AlphaRx plans listing of subsidiary on Canadian exchange

Oxygen Biotherapeutics commences distributing newly formulated Dermacyte Oxygen Concentrate

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News